Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma

Published:2019-09 Issue: Volume:14 Page:266-278
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Deng Haoyu,Liu Huitao,de Silva Tanya,Xue YuanChao,Mohamud Yasir,Ng Chen Seng,Qu Junyan,Zhang Jingchun,Jia William W.G.,Lockwood William W.,Luo Honglin

Funder

Terry Fox Research Institute

Natural Sciences and Engineering Research Council of Canada

Canadian Lung Association

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference65 articles.

1. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat. Rev. Cancer,2014

2. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

3. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

4. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

5. EGFR-TKI resistance in NSCLC patients: mechanisms and strategies;Lin;Am. J. Cancer Res.,2014

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements of gene therapy in cancer treatment: A comprehensive review;Pathology - Research and Practice;2024-09

2. Oncolytic Viruses in Cancer Immunotherapy;Advanced Therapeutics;2024-05-22

3. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320;International Journal of Molecular Sciences;2024-05-22

4. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03

5. Harnessing Pyroptosis for Cancer Immunotherapy;Cells;2024-02-16